Back
Esquire Financial Holdings Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
74
ESQ
Esquire Financial Holdings
Last Price:
64.16
Seasonality Move:
12.67%
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
124.65
Seasonality Move:
-1.39%
Buy
74
Esquire Financial Holdings (ESQ)
is a Buy
Is Esquire Financial Holdings a Buy, Sell or Hold?
- The current Esquire Financial Holdings [ESQ] share price is $64.38. The Score for ESQ is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- ESQ is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ESQ Stock Price Chart
What is Esquire Financial Holdings's stock price today?
-
The Esquire Financial Holdings share price today is $64.38
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESQ is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $124.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
ESQ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.47 | Buy |
Relative Strength Index (14 RSI): | 66.55 | Buy |
Chaikin Money Flow: | 14479 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (60 - 63.16) | Buy |
Bollinger Bands (100): | (47.35 - 60.11) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.18 | Sell |
Relative Strength Index (14 RSI): | 35.54 | Sell |
Chaikin Money Flow: | -49995 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (124.27 - 135.95) | Sell |
Bollinger Bands (100): | (123.89 - 147.49) | Sell |
ESQ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 63.58 | Buy |
20-day SMA: | 61.77 | Buy |
50-day SMA: | 59.51 | Buy |
200-day SMA: | 51.09 | Buy |
8-day EMA: | 63.32 | Buy |
20-day EMA: | 62.02 | Buy |
50-day EMA: | 59.07 | Buy |
200-day EMA: | 52.28 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.45 | Sell |
20-day SMA: | 127.75 | Sell |
50-day SMA: | 135.2 | Sell |
200-day SMA: | 127.53 | Sell |
8-day EMA: | 125.39 | Sell |
20-day EMA: | 128.04 | Sell |
50-day EMA: | 132.59 | Sell |
200-day EMA: | 128.64 | Sell |
Esquire Financial Holdings Earnings Growth & ESQ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.10 per share, an increase this year of $0.57 per share, and an increase next year of $0.43 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Esquire Financial Holdings Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |